Candidiasis: Clinical Trials

7 trials for Candidiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Terminated 7

Follow Candidiasis: new trials by email Literature Review of Candidiasis trials Research Report on Candidiasis

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole
SCY-078, Fluconazole, Echinocandin - Candidiasis, Invasive, Candidemia
Phase 3TerminatedScynexis, Inc.682022-08-032026-08-10
Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis
micafungin, amphotericin B deoxycholate - Candidiasis
Phase 3TerminatedAstellas Pharma Global Development, Inc.302013-02-012015-11-04
A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis
Anidulafungin/Fluconazole - Candidemia
Phase 3TerminatedPfizer172010-12-012015-10-28
A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients
voriconazole - Candidiasis
Phase 3TerminatedPfizer232010-10-012016-06-23
An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System
Active Anidulafungin, Active Caspofungin - Fungemia, Neutropenia
Phase 3TerminatedPfizer212009-08-012012-12-20
An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida
Active anidulafungin, Active Caspofungin - Candidiasis, Fungemia
Phase 3TerminatedPfizer412009-04-012013-08-01
Caspofungin Study for Fungal Infections in Adults in Critical Care Settings
Caspofungin, Placebo - Candidiasis
Phase 3TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)12002004-10-012014-12-05

Narrower conditions

Candidemia (5)  ·  Candidiasis, Invasive (3)  ·  Mycoses (3)  ·  Torulopsis (3)  ·  Fungemia (2)  ·  Neutropenia (1)

Broader conditions

Bacterial Infections and Mycoses (7)  ·  Infections (7)  ·  Inflammation (5)  ·  Invasive Fungal Infections (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Sepsis (5)  ·  Systemic Inflammatory Response Syndrome (5)  ·  Mycoses (4)  ·  Fungemia (3)  ·  Candidiasis, Invasive (2)  ·  Agranulocytosis (1)  ·  Cytopenia (1)  ·  Hematologic Diseases (1)

Interventions

Anidulafungin (2)  ·  Caspofungin (2)  ·  Fluconazole (2)  ·  Micafungin (2)  ·  Amphotericin B (1)  ·  Echinocandins (1)  ·  Injections (1)  ·  Voriconazole (1)  ·  amphotericin B, deoxycholate drug combination (1)  ·  ibrexafungerp (1)

Sponsors

Pfizer (4)  ·  Astellas Pharma Global Development, Inc. (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Scynexis, Inc. (1)

Countries

United States (4)  ·  Bulgaria (3)  ·  Canada (3)  ·  China (3)  ·  Belgium (2)  ·  France (2)  ·  Greece (2)  ·  Hungary (2)  ·  Israel (2)  ·  Italy (2)  ·  Philippines (2)  ·  Poland (2)  ·  Romania (2)  ·  Russia (2)  ·  Slovakia (2)

Top investigators

David Angulo, MD (1)

Results publications

PMID 28459966, PMID 28597967, PMID 33891293, PMID 27636722, PMID 29596222, PMID 31280481

NIH funding

2009 (1)